Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
BioSpace
Tue, 11/14/23 - 10:55 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Janssen reports data from Phase III trial of lung cancer drug
Clinical Trials Arena
Tue, 10/24/23 - 10:21 am
JNJ
Janssen
Rybrevant
clinical trials
non-small cell lung cancer
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
ESMO
non-small cell lung cancer
Roche
Alecensa
AstraZeneca
Tagrisso
JNJ
Rybrevant
Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer
BioSpace
Wed, 10/18/23 - 10:17 am
Genentech
Alecensa
ALK inhibitors
non-small cell lung cancer
ESMO
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval
BioSpace
Tue, 10/17/23 - 09:36 pm
Merck
Keytruda
non-small cell lung cancer
AZ’s Tagrisso plus chemo get fast FDA review for lung cancer
Pharmaphorum
Mon, 10/16/23 - 10:20 am
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
EGFR-positive non-small cell lung cancer
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Merck
Keytruda
non-small cell lung cancer
FDA Says ‘Systemic Bias’ in Amgen’s Lumakras Trial Ahead of Adcomm Meeting
BioSpace
Wed, 10/4/23 - 11:08 am
Amgen
Lumakras
non-small cell lung cancer
FDA
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Managed Healthcare Executive
Tue, 10/3/23 - 10:34 am
Takeda
Exkivity
clinical trials
non-small cell lung cancer
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
JNJ
non-small cell lung cancer
AstraZeneca
Rybrevant
lazertinib
Tagrisso
Latest trial win further supports expanded use of Bristol Myers’ Opdivo in lung cancer
BioPharma Dive
Sun, 09/24/23 - 08:54 pm
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
Clinical Trials Arena
Fri, 09/22/23 - 12:00 pm
Gilead Sciences
Trodelvy
TROP-2
non-small cell lung cancer
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
Fierce Biotech
Tue, 09/12/23 - 12:00 pm
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
non-small cell lung cancer
Dato-DXd
WCLC: Tagrisso's chemo combo shows edge, but AstraZeneca thinks monotherapy remains king in lung cancer
Fierce Pharma
Mon, 09/11/23 - 12:27 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
Mirati’s Krazati remains effective in two-year follow-up of NSCLC patients
Clinical Trials Arena
Mon, 09/11/23 - 12:29 pm
Mirati Therapeutics
non-small cell lung cancer
Krazati
clinical trials
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Roche
Tigit
clinical trials
lung cancer
non-small cell lung cancer
tiragolumab
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Genentech
Blueprint Medicines
Gavreto
non-small cell lung cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »